Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Ewimed Sweden AB
AB
Active
Org 5566908207
Adelgatan 21, 211 22
Malmö
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2005 · 20 years old
13 employees
Monitor
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Ewimed Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
49M
36M
24M
12M
0M
2021: 30M
30M
2021
2022: 33M (+10% vs 2021)
33M
+10%
2022
2023: 35M (+6% vs 2022)
35M
+6%
2023
2024: 37M (+6% vs 2023)
37M
+6%
2024
2025: 39M (+5% vs 2024)
39M
+5%
2025
EBITDA
SEK millions
5M
4M
2M
1M
0M
2021: 3M
3M
2021
2022: 3M (0% vs 2021)
3M
0%
2022
2023: 2M (-33% vs 2022)
2M
-33%
2023
2024: 0M (-100% vs 2023)
0M
-100%
2024
2025: 4M
4M
2025
Income statement
SEK thousands
Item
2025
2024
2023
2022
2021
Revenue
38 791
36 667
34 534
33 403
30 457
Staff expenses
−12 310
—
—
—
—
EBITDA
3 516
−377
1 680
3 003
3 356
Depreciation & amort.
−0
−0
−0
−0
−0
EBIT
3 516
−377
1 680
3 003
3 356
Net financials
88
318
−24
−27
—
Profit before tax
3 604
−59
1 656
2 976
3 357
Tax
−800
−57
−383
−645
−169
Net profit
2 804
−116
1 273
2 331
3 188
Balance sheet
SEK thousands
Item
2025
2024
2023
2022
2021
Total assets
20 903
17 116
16 663
17 127
15 060
Equity
13 220
10 416
10 532
9 259
6 928
Long-term debt
0
0
0
0
0
Short-term debt
7 683
6 700
6 131
7 868
8 132
Total debt
7 683
6 700
6 131
7 868
8 132
Financial ratios
5-year trend
EBITDA margin
9,1 %
This company
15,8 %
Market median
This company
Market median
42% below market
2021
2025
Equity ratio
63,2 %
This company
38,2 %
Market median
This company
Market median
65% above market
2021
2025
Return on equity
21,2 %
This company
18,4 %
Market median
This company
Market median
15% above market
2021
2025
Net profit margin
7,2 %
This company
8,1 %
Market median
This company
Market median
11% below market
2021
2025
Asset turnover
1,86×
This company
1,12×
Market median
This company
Market median
66% above market
2021
2025
Debt / equity
0,58×
This company
0,62×
Market median
This company
Market median
6% below market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
More on Ewimed Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
